In the CKD model, calcitriol treatment lowered TRPM7 protein levels in blood vessels, whereas combining magnesium with calcitriol reduced vascular calcification by boosting TRPM7 expression and magnesium levels in the vascular microenvironment (Zelt et al., 2015). Here, TRPM7 is linked to chronic kidney disease.